These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27581819)

  • 1. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
    Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.
    Shelake S; Sankpal UT; Paul Bowman W; Wise M; Ray A; Basha R
    Invest New Drugs; 2017 Apr; 35(2):158-165. PubMed ID: 28025760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
    Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
    Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.
    Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R
    Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
    Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
    Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leukemic response of a NSAID, tolfenamic acid.
    Sutphin RM; Connelly SF; Lee CM; Sankpal UT; Eslin D; Khan M; Pius H; Basha R
    Target Oncol; 2014 Jun; 9(2):135-44. PubMed ID: 23609055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
    Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
    Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
    Shelake S; Eslin D; Sutphin RM; Sankpal UT; Wadwani A; Kenyon LE; Tabor-Simecka L; Bowman WP; Vishwanatha JK; Basha R
    Int J Dev Neurosci; 2015 Nov; 46():92-9. PubMed ID: 26287661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
    Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
    Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.
    Momeny M; Ghasemi R; Valenti G; Miranda M; Zekri A; Zarrinrad G; Javadikooshesh S; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Tumour Biol; 2016 Mar; 37(3):3913-23. PubMed ID: 26482609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
    Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
    Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.
    Mir R; Stanzani E; Martinez-Soler F; Villanueva A; Vidal A; Condom E; Ponce J; Gil J; Tortosa A; Giménez-Bonafé P
    Gynecol Oncol; 2014 Jan; 132(1):211-20. PubMed ID: 24262875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
    Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
    Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
    Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
    Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.
    Zhang Z; Liao H; Chen X; Zheng Y; Liu Y; Tao X; Gu C; Dong L; Duan T; Yang Y; Liu X; Yu Y; Feng Y
    Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):69-74. PubMed ID: 21074309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.